HEADER TRANSFERASE 03-MAR-15 4YJO TITLE THE KINASE DOMAIN OF HUMAN SPLEEN TYROSINE (SYK) IN COMPLEX WITH TITLE 2 GTC000222 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE SYK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 355-635; COMPND 5 SYNONYM: SPLEEN TYROSINE KINASE,P72-SYK; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SYK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9 KEYWDS SYK, NON-RECEPTOR TYROSINE KINASE, SPLEEN TYROSINE KINASE, KEYWDS 2 TRANSFERASE, PHOSPHORYLATION, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 3 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.O.SOMERS,M.NEU REVDAT 2 01-MAY-24 4YJO 1 REMARK REVDAT 1 30-SEP-15 4YJO 0 JRNL AUTH J.LIDDLE,F.L.ATKINSON,M.D.BARKER,P.S.CARTER,N.R.CURTIS, JRNL AUTH 2 R.P.DAVIS,C.DOUAULT,M.C.DICKSON,D.ELWES,N.S.GARTON,M.GRAY, JRNL AUTH 3 T.G.HAYHOW,C.I.HOBBS,E.JONES,S.LEACH,K.LEAVENS,H.D.LEWIS, JRNL AUTH 4 S.MCCLEARY,M.NEU,V.K.PATEL,A.G.PRESTON,C.RAMIREZ-MOLINA, JRNL AUTH 5 T.J.SHIPLEY,P.A.SKONE,N.SMITHERS,D.O.SOMERS,A.L.WALKER, JRNL AUTH 6 R.J.WATSON,G.G.WEINGARTEN JRNL TITL DISCOVERY OF GSK143, A HIGHLY POTENT, SELECTIVE AND ORALLY JRNL TITL 2 EFFICACIOUS SPLEEN TYROSINE KINASE INHIBITOR. JRNL REF BIOORG. MED. CHEM. LETT. V. 21 6188 2011 JRNL REFN ESSN 1464-3405 JRNL PMID 21903390 JRNL DOI 10.1016/J.BMCL.2011.07.082 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 87.0 REMARK 3 NUMBER OF REFLECTIONS : 28936 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1539 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.64 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1968 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 81.98 REMARK 3 BIN R VALUE (WORKING SET) : 0.3770 REMARK 3 BIN FREE R VALUE SET COUNT : 116 REMARK 3 BIN FREE R VALUE : 0.4110 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2171 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 37 REMARK 3 SOLVENT ATOMS : 235 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.43 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.35000 REMARK 3 B22 (A**2) : -2.93000 REMARK 3 B33 (A**2) : 4.99000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.88000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.113 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.114 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.113 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.542 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.972 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.954 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2281 ; 0.011 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 1573 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3079 ; 1.458 ; 1.967 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3825 ; 1.241 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 269 ; 4.507 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 107 ;32.168 ;24.393 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 415 ;11.888 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;18.882 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 315 ; 0.093 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2501 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 472 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 4YJO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-MAR-15. REMARK 100 THE DEPOSITION ID IS D_1000207385. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-JUN-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97935 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM 6.2.4 REMARK 200 DATA SCALING SOFTWARE : SCALA 3.2.5 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30502 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 28.784 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.6 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.04800 REMARK 200 R SYM (I) : 0.04800 REMARK 200 FOR THE DATA SET : 16.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 82.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.48800 REMARK 200 R SYM FOR SHELL (I) : 0.48800 REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: IN-HOUSE SYK MODEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.55 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% JEFFAMINE ED-2001, 10% GLYCEROL, REMARK 280 0.1M MES PH6.8, 5MM TCEP, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 42.41050 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 190 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13380 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 ILE A 358 REMARK 465 ARG A 359 REMARK 465 PRO A 360 REMARK 465 LYS A 361 REMARK 465 GLU A 362 REMARK 465 GLN A 529 REMARK 465 THR A 530 REMARK 465 HIS A 531 REMARK 465 VAL A 633 REMARK 465 VAL A 634 REMARK 465 ASN A 635 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 1034 O HOH A 1035 2.01 REMARK 500 OH TYR A 525 O HOH A 1008 2.07 REMARK 500 OE2 GLU A 473 O HOH A 1004 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 616 NE - CZ - NH2 ANGL. DEV. = -3.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 394 -52.94 -139.35 REMARK 500 GLU A 407 43.41 38.97 REMARK 500 ALA A 441 -136.19 -128.65 REMARK 500 ASP A 494 41.25 -151.29 REMARK 500 ASP A 512 80.70 59.58 REMARK 500 TRP A 609 31.41 -91.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4DF A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 702 DBREF 4YJO A 355 635 UNP P43405 KSYK_HUMAN 355 635 SEQRES 1 A 281 PRO GLU GLU ILE ARG PRO LYS GLU VAL TYR LEU ASP ARG SEQRES 2 A 281 LYS LEU LEU THR LEU GLU ASP LYS GLU LEU GLY SER GLY SEQRES 3 A 281 ASN PHE GLY THR VAL LYS LYS GLY TYR TYR GLN MET LYS SEQRES 4 A 281 LYS VAL VAL LYS THR VAL ALA VAL LYS ILE LEU LYS ASN SEQRES 5 A 281 GLU ALA ASN ASP PRO ALA LEU LYS ASP GLU LEU LEU ALA SEQRES 6 A 281 GLU ALA ASN VAL MET GLN GLN LEU ASP ASN PRO TYR ILE SEQRES 7 A 281 VAL ARG MET ILE GLY ILE CYS GLU ALA GLU SER TRP MET SEQRES 8 A 281 LEU VAL MET GLU MET ALA GLU LEU GLY PRO LEU ASN LYS SEQRES 9 A 281 TYR LEU GLN GLN ASN ARG HIS VAL LYS ASP LYS ASN ILE SEQRES 10 A 281 ILE GLU LEU VAL HIS GLN VAL SER MET GLY MET LYS TYR SEQRES 11 A 281 LEU GLU GLU SER ASN PHE VAL HIS ARG ASP LEU ALA ALA SEQRES 12 A 281 ARG ASN VAL LEU LEU VAL THR GLN HIS TYR ALA LYS ILE SEQRES 13 A 281 SER ASP PHE GLY LEU SER LYS ALA LEU ARG ALA ASP GLU SEQRES 14 A 281 ASN TYR TYR LYS ALA GLN THR HIS GLY LYS TRP PRO VAL SEQRES 15 A 281 LYS TRP TYR ALA PRO GLU CYS ILE ASN TYR TYR LYS PHE SEQRES 16 A 281 SER SER LYS SER ASP VAL TRP SER PHE GLY VAL LEU MET SEQRES 17 A 281 TRP GLU ALA PHE SER TYR GLY GLN LYS PRO TYR ARG GLY SEQRES 18 A 281 MET LYS GLY SER GLU VAL THR ALA MET LEU GLU LYS GLY SEQRES 19 A 281 GLU ARG MET GLY CYS PRO ALA GLY CYS PRO ARG GLU MET SEQRES 20 A 281 TYR ASP LEU MET ASN LEU CYS TRP THR TYR ASP VAL GLU SEQRES 21 A 281 ASN ARG PRO GLY PHE ALA ALA VAL GLU LEU ARG LEU ARG SEQRES 22 A 281 ASN TYR TYR TYR ASP VAL VAL ASN HET 4DF A 701 31 HET GOL A 702 6 HETNAM 4DF 5-CHLORO-N~2~-(1,1-DIOXIDO-2,3-DIHYDRO-1,2- HETNAM 2 4DF BENZOTHIAZOL-6-YL)-N~4~-ETHYL-N~4~-(1H-INDAZOL-4-YL) HETNAM 3 4DF PYRIMIDINE-2,4-DIAMINE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 4DF C20 H18 CL N7 O2 S FORMUL 3 GOL C3 H8 O3 FORMUL 4 HOH *235(H2 O) HELIX 1 AA1 ASP A 366 LYS A 368 5 3 HELIX 2 AA2 ASN A 406 ASN A 409 5 4 HELIX 3 AA3 ASP A 410 LEU A 427 1 18 HELIX 4 AA4 LEU A 456 ASN A 463 1 8 HELIX 5 AA5 LYS A 467 SER A 488 1 22 HELIX 6 AA6 ALA A 496 ARG A 498 5 3 HELIX 7 AA7 PRO A 535 TYR A 539 5 5 HELIX 8 AA8 ALA A 540 TYR A 547 1 8 HELIX 9 AA9 SER A 550 SER A 567 1 18 HELIX 10 AB1 LYS A 577 LYS A 587 1 11 HELIX 11 AB2 PRO A 598 TRP A 609 1 12 HELIX 12 AB3 ASP A 612 ARG A 616 5 5 HELIX 13 AB4 GLY A 618 ASP A 632 1 15 SHEET 1 AA1 5 LEU A 370 GLY A 380 0 SHEET 2 AA1 5 GLY A 383 GLN A 391 -1 O LYS A 387 N GLU A 373 SHEET 3 AA1 5 VAL A 396 LEU A 404 -1 O ILE A 403 N THR A 384 SHEET 4 AA1 5 TRP A 444 GLU A 449 -1 O LEU A 446 N LYS A 402 SHEET 5 AA1 5 MET A 435 GLU A 440 -1 N GLY A 437 O VAL A 447 SHEET 1 AA2 3 GLY A 454 PRO A 455 0 SHEET 2 AA2 3 VAL A 500 THR A 504 -1 O LEU A 502 N GLY A 454 SHEET 3 AA2 3 TYR A 507 ILE A 510 -1 O LYS A 509 N LEU A 501 SHEET 1 AA3 2 PHE A 490 VAL A 491 0 SHEET 2 AA3 2 LYS A 517 ALA A 518 -1 O LYS A 517 N VAL A 491 SHEET 1 AA4 2 TYR A 526 LYS A 527 0 SHEET 2 AA4 2 LYS A 548 PHE A 549 -1 O PHE A 549 N TYR A 526 SITE 1 AC1 14 LEU A 377 GLY A 378 ALA A 400 LYS A 402 SITE 2 AC1 14 GLU A 420 VAL A 433 MET A 448 GLU A 449 SITE 3 AC1 14 MET A 450 ALA A 451 GLY A 454 PRO A 455 SITE 4 AC1 14 LEU A 501 ASP A 512 SITE 1 AC2 4 ASN A 406 GLN A 477 HIS A 506 HOH A 810 CRYST1 39.936 84.821 40.412 90.00 99.24 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025040 0.000000 0.004072 0.00000 SCALE2 0.000000 0.011790 0.000000 0.00000 SCALE3 0.000000 0.000000 0.025070 0.00000